(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIOGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BIOGEN

ST13

US500000086964285

Class

5

Filing

86964285

Registration

5085981

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

03/14/2026

Trademark type

Combined

Nice classes

5

Filing date

04/05/2016

Registration date

11/22/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/25/2023

Last transaction

03/14/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

First use anywhere

07/08/2015

First use in commerce

07/08/2015

Drawing code

3

Owner type

03

Owner location

CAMBRIDGE, MA, US

Examiner

GEARHART, DAVID JAMES

Law office

M30

Current location

TMO LAW OFFICE 112

Holders and representatives

Holders

Biogen MA Inc.
Biogen MA Inc.

Representatives

Douglas A. Rettew Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of neurologic disorders and hemophilia

Publications

History of USPTO decisions and trademark events.

29 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

03/13/2026

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

03/25/2023

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

03/25/2023

PRAN

POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED

03/25/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/18/2023

E815

TEAS SECTION 8 & 15 RECEIVED

09/02/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

11/22/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/08/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/08/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/08/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/08/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/08/2021

CCON

COUNTERCLAIM OPP. NO. 999999

01/25/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/06/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

11/22/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/06/2016

PUBO

PUBLISHED FOR OPPOSITION

09/06/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/17/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/02/2016

ALIE

ASSIGNED TO LIE

08/01/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/20/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

07/20/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/20/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

07/20/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/20/2016

DOCK

ASSIGNED TO EXAMINER

07/20/2016

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

04/09/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/08/2016

NWAP

NEW APPLICATION ENTERED

04/08/2016

Continuous trademark protection

Get notified about every new filing that threatens BIOGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.